Phase Ib study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer

被引：0
|
作者：
Broekman, K. E. [1 ]
Reyners, A. K. L. [1 ]
Touw, D. J. [2 ]
Hof, M. A. J. [2 ]
Jalving, M. [1 ]
机构：
[1] Univ Hosp Groningen UMCG, Med Oncol, Groningen, Netherlands
[2] Univ Med Ctr Groningen UMCG, Clin Pharm & Pharmacol, Groningen, Netherlands
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
992P
引用
收藏
页码：354 / 354
页数：1
相关论文
共 50 条
  • [1] Phase I study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer
    K. Esther Broekman
    Marieke A. J. Hof
    Daan J. Touw
    Jourik A. Gietema
    Hans W. Nijman
    Joop D. Lefrandt
    An K. L. Reyners
    Mathilde Jalving
    Investigational New Drugs, 2020, 38 : 1454 - 1462
  • [2] Phase I study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer
    Broekman, K. Esther
    Hof, Marieke A. J.
    Touw, Daan J.
    Gietema, Jourik A.
    Nijman, Hans W.
    Lefrandt, Joop D.
    Reyners, An K. L.
    Jalving, Mathilde
    INVESTIGATIONAL NEW DRUGS, 2020, 38 (05) : 1454 - 1462
  • [3] Phase I/II study of the combination of carboplatin and paclitaxel as first-line chemotherapy in patients with advanced epithelial ovarian cancer
    duBois, A
    Luck, HJ
    Bauknecht, T
    Mobus, V
    Bochtler, H
    Diergarten, K
    Meerpohl, HG
    ANNALS OF ONCOLOGY, 1997, 8 (04) : 355 - 361
  • [4] Sorafenib in combination with carboplatin and paclitaxel as neoadjuvant chemotherapy in patients with advanced ovarian cancer
    Martin Pölcher
    Meike Eckhardt
    Christoph Coch
    Matthias Wolfgarten
    Kirsten Kübler
    Gunther Hartmann
    Walther Kuhn
    Christian Rudlowski
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 203 - 207
  • [5] Sorafenib in combination with carboplatin and paclitaxel as neoadjuvant chemotherapy in patients with advanced ovarian cancer
    Poelcher, Martin
    Eckhardt, Meike
    Coch, Christoph
    Wolfgarten, Matthias
    Kuebler, Kirsten
    Hartmann, Gunther
    Kuhn, Walther
    Rudlowski, Christian
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (01) : 203 - 207
  • [6] Pharmacokinetics of combination chemotherapy with paclitaxel and carboplatin in a patient with advanced epithelial ovarian cancer undergoing hemodialysis
    Kodama, Junichi
    Sasaki, Aiko
    Masahiro, Satoko
    Seki, Noriko
    Kusumoto, Tomoyuki
    Nakamura, Keiichiro
    Hongo, Atsushi
    Hiramatsu, Yuji
    ONCOLOGY LETTERS, 2010, 1 (03) : 511 - 513
  • [7] Paclitaxel and carboplatin combination chemotherapy in a hemodialysis patient with advanced ovarian cancer
    Watanabe, M
    Aoki, Y
    Tomita, M
    Sato, T
    Takaki, Y
    Kato, N
    Kikuchi, M
    Kase, H
    Tanaka, K
    GYNECOLOGIC ONCOLOGY, 2002, 84 (02) : 335 - 338
  • [8] Paclitaxel (Taxol)/carboplatin combination chemotherapy in the treatment of advanced ovarian cancer
    Ozols, RF
    SEMINARS IN ONCOLOGY, 2000, 27 (03) : 3 - 7
  • [9] Phase II study of the combination carboplatin and paclitaxel in patients with ovarian cancer
    Huinink, WWT
    vanWarmerdam, LJC
    Helmerhorst, TJ
    Schaefers, MCW
    Beijnen, JH
    Rodenhuis, S
    ANNALS OF ONCOLOGY, 1997, 8 (04) : 351 - 354
  • [10] Paclitaxel and carboplatin chemotherapy administered during pregnancy for advanced epithelial ovarian cancer
    Méndez, LE
    Mueller, A
    Salom, E
    González-Quintero, VH
    OBSTETRICS AND GYNECOLOGY, 2003, 102 (05): : 1200 - 1202
12345